Axonics, Inc.

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

NASDAQ:AXNX

Axonics, Inc.

Last Close

66.69

29/04 16:59

Market Cap

3.40B

Beta: 0.39

Volume Today

325.49K

Avg: 569.88K

PE Ratio

−278.47

PFCF: −3,945.94

locale

market

industry

website

ipo date

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics

Please Sign In To Use The Chat